Your email has been successfully added to our mailing list.

×
-0.0152727272727272 -0.0136363636363637 -0.0181818181818182 -0.00454545454545465 9.09090909090809E-05 0.0227272727272726 -0.000181818181818162 -0.00818181818181829
Stock impact report

Thermo Fisher's (TMO) CDx Gets FDA's Nod for Synovial Sarcoma [Yahoo! Finance]

Adaptimmune Therapeutics plc - American Depositary Shares (ADAP) 
Last adaptimmune therapeutics plc - american depositary shares earnings: 5/9 07:30 am Check Earnings Report
Company Research Source: Yahoo! Finance
diagnostic (CDx) alongside Adaptimmune 's ADAP newly approved T-cell receptor (TCR) therapy, TECELRA (afamitresgene autoleucel). The latter is the first engineered cell therapy for a solid tumor cancer approved in the United States and the first new therapy option in more than a decade for synovial sarcoma — a rare, soft tissue cancer that most commonly impacts young adults. The recent development will enhance Thermo Fisher's Transplant Diagnostics business, which is part of the Specialty Diagnostics segment. News in Detail TECELRA is approved for treating adults with unresectable or metastatic synovial sarcoma who have received prior chemotherapy, are certain HLA (human leukocyte antigen) type positive and whose tumor expresses the MAGE-A4 antigen, as determined by FDA-approved or cleared CDx devices. Cancer immunotherapies, including TCR therapies, have become increasingly powerful tools in cancer treatment, particularly for patients with metastatic or unresectable tumors. T Show less Read more
Impact Snapshot
Event Time:
ADAP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ADAP alerts
Opt-in for
ADAP alerts

from News Quantified
Opt-in for
ADAP alerts

from News Quantified